Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: Complex roles for oxygen-based species and temperature regulation

Neuroscience

Volumn 107, Issue 2, 2001, Pages 265-274

  Krasnova, I N ^a   Ladenheim, B ^a   Jayanthi, S ^a   Oyler, J ^a   Moran, T H ^b   Huestis, M A ^a   Cadet, J L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Antioxidant enzymes; Caudate putamen; Dopamine; Superoxide radicals

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; AMPHETAMINE; CARRIER PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; DOPAMINE; DOPAMINE TRANSPORTER; IODINE 125;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; HYPOTHERMIA; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STRIATE CORTEX; THERMOREGULATION; TRANSGENIC MOUSE;

3,4-DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; ANIMALS; BLOTTING, WESTERN; BODY TEMPERATURE REGULATION; BRAIN; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FREE RADICALS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROPEPTIDES; PHENOTYPE; PRESYNAPTIC TERMINALS; PUTAMEN; SPECIES SPECIFICITY; SUPEROXIDE DISMUTASE; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 0035900604     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00351-7     Document Type: Article

References (61)

1. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and nonprotective agents
2. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice
3. Effect of D-amphetamine on extracellular dopamine content and generation of hydroxyl radicals in the striatum of freely moving rats
4. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
5. 125I]iodophenyl)tropane-2 β-carboxylic acid isopropyl ester
6. Free radicals in the pathobiology of brain dopamine systems
7. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice
8. Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn dismutase transgenic mice
9. Intracellular antioxidants: From chemical to biochemical mechanisms
10. Catalase activity
11. Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects
12. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity
13. Cytokines as endogenous pyrogens
14. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration
15. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome
16. Rapid and reversible effects of methamphetamine on dopamine transporters
17. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action
18. MPTP- and MPP+-induced effects on body temperature exhibit age- and strain-dependence in mice
19. -), superoxide dismutases and related matters
20. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice
21. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice
22. Oxidative stress induced in pathologies: The role of antioxidants
23. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: Attenuation in CuZn-superoxide dismutase transgenic mice
24. Amphetamine induces hydroxyl radical formation in the striatum of rats
25. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice
26. Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy)
27. Involvement of prostaglandins and histamine in radiation-induced temperature responses in rats
28. Involvement of superoxide dismutase and glutathione peroxidase in attenuation of radiation-induced hyperthermia by interleukin-1 alpha in rats
29. Exposure to heavy charged particles affects thermoregulation in rats
30. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters
31. Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice
32. Evaluation of the effects of α-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine
33. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters
34. Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6
35. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine
36. Systemic administration of D-amphetamine induced a delayed production of nitric oxide in the striatum of rats
37. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat
38. L-methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine
39. Importance of Se-glutathione peroxide, catalase, and Cu/Zn-SOD for cell survival against oxidative stress
40. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse
41. Neurotoxicity of D-amphetamine in the C57BL/6J and CD-1 mouse. Interactions with stress and the adrenal system
42. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice
43. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: Plasmalemmal dopamine transporter versus vesicular monoamine transporter
44. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers
45. Free radicals in biology: Oxidative stress and the effects of ionizing radiation
46. Hypothalamus and thermogenesis
47. CNS regulation of thermogenesis
48. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: An in vitro model
49. Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
50. 3H]WIN 35,428 to central dopamine transporters
51. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice
52. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport
53. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments
54. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate
55. Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes
56. Intra-striatal infusion of D-amphetamine induces hydroxyl radical formation: Inhibition by MK-801 pretreatment
57. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat
58. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease
59. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: Implications for methamphetamine-induced dopaminergic neurotoxicity
60. Rapid and simple method for measuring of biogenic amines and metabolites in brain homogenates by HPLC-electrochemical detection